Mode
Text Size
Log in / Sign up
N/A N=452 Randomized Prevention

Smoke-free Home Intervention in Permanent Supportive Housing

Smoking Cessation · Second Hand Tobacco Smoke

Enrolled (actual)
452
Serious AEs
0.0%
Results posted
May 2026
Primary outcome: Primary: Proportion of Resident-participants Who Adopt a Smoke-free Home Voluntarily — 0.068; 0.048 proportion of resident-participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Resident counselling (Behavioral); Staff Training (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of California, San Francisco
Primary completion
Mar 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Proportion of Resident-participants Who Adopt a Smoke-free Home Voluntarily
0.068; 0.048
SECONDARY
Proportion of Resident-participants Who Achieve Abstinence
0.063; 0.0096

Summary

The focus of this study is on expanding access to voluntary smoke-free homes to formerly homeless residents residing in permanent supportive housing and examining the impact of this intervention on reducing tobacco-caused disparities. In this study, the principal investigator will conduct a multi-site, community-based cluster-randomized wait-list controlled trial of the multi-faceted smoke-free home intervention among 400 permanent supportive housing residents residing in 20 permanent supportive housing sites across the San Francisco Bay Area with the goal of increasing voluntary adoption of smoke-free homes.

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or older
  • Ability to understand study procedures and to comply with them for the entire length of the study.
  • Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
  • Current smokers [(smoked at least 100 cigarettes in lifetime, daily or non-daily smoking in the past 7 days and at least 5 cigarettes per day, verified by expired Carbon Monoxide (CO)>= 8 parts per million (ppm) who smoke in their homes.
  • Expect to live in the PSH site for at least 12 months
  • English proficient.

Exclusion Criteria

  • Contraindication to any study-related procedure or assessment.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04855357). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search